Back
UMB Financial Corp. Vs. Oruka Therapeutics, Inc. Industry Stock Comparison
Sell
49
UMBF
UMB Financial Corp.
Last Price:
$115.01
Seasonality Move:
2.13%
Sell
26
ORKA
Oruka Therapeutics, Inc.
Last Price:
$30.39
Seasonality Move:
-9.32%
Sell
49
UMB Financial Corp. (UMBF)
is a Sell
Is UMB Financial Corp. a Buy, Sell or Hold?
-
The current UMB Financial Corp. [UMBF] share price is $115.04. The Score for UMBF is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.
-
UMBF is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
26
Oruka Therapeutics, Inc. (ORKA)
is a Sell
Is Oruka Therapeutics, Inc. a Buy, Sell or Hold?
-
The current Oruka Therapeutics, Inc. [ORKA] share price is $30.31. The Score for ORKA is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
-
ORKA is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
UMBF Stock Price Chart
What is UMB Financial Corp.'s stock price today?
-
The UMB Financial Corp. share price today is $115.04Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and UMBF is experiencing selling pressure, which indicates risk of future bearish movement.
ORKA Stock Price Chart
What is Oruka Therapeutics, Inc.'s stock price today?
-
The Oruka Therapeutics, Inc. share price today is $30.31The current trend is moderately bullish and ORKA is experiencing slight buying pressure.
UMBF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 32.19 | Buy |
| Relative Strength Index (14 RSI): | 46.51 | Sell |
| Chaikin Money Flow: | -362081 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (113.48 - 119.4) | Sell |
| Bollinger Bands (100): | (110.25 - 120.97) | Sell |
ORKA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.57 | Buy |
| Relative Strength Index (14 RSI): | 51.81 | Buy |
| Chaikin Money Flow: | 234570 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (29 - 31.58) | Buy |
| Bollinger Bands (100): | (16.97 - 29.87) | Buy |
UMBF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 118.09 | Sell |
| 20-day SMA: | 117.61 | Sell |
| 50-day SMA: | 112.51 | Buy |
| 200-day SMA: | 109.18 | Buy |
| 8-day EMA: | 107.89 | Buy |
| 20-day EMA: | 74.62 | Buy |
| 50-day EMA: | 38.98 | Buy |
| 200-day EMA: | 11.26 | Buy |
ORKA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 31.21 | Sell |
| 20-day SMA: | 30.53 | Sell |
| 50-day SMA: | 28.99 | Buy |
| 200-day SMA: | 17.48 | Buy |
| 8-day EMA: | 30.57 | Sell |
| 20-day EMA: | 30.26 | Buy |
| 50-day EMA: | 28.26 | Buy |
| 200-day EMA: | 21.62 | Buy |
UMB Financial Corp. Earnings Growth & UMBF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.46 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.85 per share, and an increase next year of $1.14 per share.
Oruka Therapeutics, Inc. Earnings Growth & ORKA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.32 per share, and a decrease next year of $0.42 per share.
UMB Financial Corp. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Oruka Therapeutics, Inc. Technical Analysis
| Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | Dec 30 | Dec 31 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | 30 | 31 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||